FAQ: Lantern Pharma's AI Platform Partnership with Hoth Therapeutics for Blood-Brain Barrier Drug Discovery

What is the main purpose of Lantern Pharma’s partnership with Hoth Therapeutics?

The partnership aims to deploy Lantern Pharma’s AI-powered PredictBBB.ai™ platform to help Hoth Therapeutics predict whether drug candidates can cross the blood-brain barrier, which is crucial for developing treatments for neurological conditions.

What is PredictBBB.ai™ and how accurate is it?

PredictBBB.ai™ is Lantern Pharma’s AI-powered platform that predicts whether drug candidates can cross the blood-brain barrier, boasting 94% accuracy in its predictions.

Why is predicting blood-brain barrier crossing important for drug development?

The blood-brain barrier presents a major challenge in developing treatments for neurological conditions, and accurately predicting which drugs can cross it helps reduce development risk and improve candidate selection.

What benefits does this AI platform provide for drug development?

The platform helps reduce development risk, improve candidate selection, and accelerate timelines for bringing neurological treatments to patients.

How does PredictBBB.ai™ relate to Lantern Pharma’s broader technology platform?

PredictBBB.ai™ is part of Lantern’s broader RADR® platform, which applies AI to optimize oncology drug discovery and development using over 200 billion oncology-focused data points.

What is Lantern Pharma’s main focus as a company?

Lantern Pharma is an AI company focused on transforming the cost, pace, and timeline of oncology drug discovery and development, with a growing pipeline of therapies for multiple cancer indications.

How efficient is Lantern Pharma’s drug development process?

Lantern’s newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $2.5 million per program.

Where can investors find more information about Lantern Pharma?

The latest news and updates relating to LTRN are available in the company’s newsroom at https://ibn.fm/LTRN

What is BioMedWire and what services do they provide?

BioMedWire is a specialized communications platform focused on biotechnology, biomedical sciences, and life sciences, providing wire solutions, article syndication, press release enhancement, social media distribution, and corporate communications solutions.